Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

19.23
+2.5014.94%
Pre-market: 18.30-0.9300-4.84%09:23 EDT
Volume:1.70M
Turnover:31.63M
Market Cap:856.92M
PE:-11.66
High:19.55
Open:16.73
Low:16.37
Close:16.73
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:24.29M
Volume Ratio:1.62
T/O Rate:7.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:3.34
PE(LYR):-10.62

Loading ...

Beta Bionics director Christy Jones sells 2,811 shares worth $39,354

Reuters
·
Jun 06

Beta Bionics management to meet with Piper Sandler

TIPRANKS
·
Jun 04

Beta Bionics launches public near real-time real-world iLet Bionic Pancreas outcomes dashboard

Reuters
·
Jun 02

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website

GlobeNewswire
·
Jun 02

Beta Bionics Is Maintained at Buy by Goldman Sachs

Dow Jones
·
May 28

Beta Bionics director Christy Jones disposes of 1,998 common shares worth $19,880.1

Reuters
·
May 27

Beta Bionics director Adam Lezack sells 1,998 common shares for $21,112.58

Reuters
·
May 27

Beta Bionics Stockholders Approve Directors and Auditor Ratification

TIPRANKS
·
May 23

Beta Bionics shareholders elect two directors at annual meeting

Reuters
·
May 23

Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (BBNX) and Arvinas Holding Company (ARVN)

TIPRANKS
·
May 22

Piper Sandler Sticks to Its Buy Rating for Beta Bionics, Inc. (BBNX)

TIPRANKS
·
May 22

Travis Steed Reaffirms Hold on Beta Bionics, Lifts Price Target to $13 on Accelerated Mint Launch but Sees Balanced Risk‑Reward

TIPRANKS
·
May 22

Beta Bionics Targets 2027 Commercial Launch of Mint Pump

TIPRANKS
·
May 22

Beta Bionics Inc - Expects Manufacturing Capacity to Meet Demand at Mint Launch

THOMSON REUTERS
·
May 22

Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development

GlobeNewswire
·
May 22

Beta Bionics Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 19

Beta Bionics Inc : Bofa Global Research Cuts Price Objective to $11 From $23

THOMSON REUTERS
·
May 18

BofA Adjusts Price Target on Beta Bionics to $11 From $23

MT Newswires Live
·
May 18

Beta Bionics price target lowered to $11 from $23 at BofA

TIPRANKS
·
May 18

Beta Bionics to present at Bank of America Securities Health Care Conference

Reuters
·
Apr 28